Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery

References

• ArlinZAFeldmanEKempinSAmsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adultsBlood19887224334353165293
   PubMed Web of Science ®Google Scholar
• LeghaSSKeatingMJMcCredieKBBodeyGPFreireichEJEvaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsBlood19826024844906953987
   PubMed Web of Science ®Google Scholar
• PaxtonJWKimSNWhitfieldLRPharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humansCancer Res1990509269226972328494
   PubMed Web of Science ®Google Scholar
• SuTLChouTCKimJY9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationshipsJ Med Chem19953817322632357650675
   PubMed Web of Science ®Google Scholar
• GamageSAFiggittDPWojcikSJStructure-activity relationships for the antileishmanial and antitrypanosomal activitiesJ Med Chem19974016263426429258370
   PubMed Web of Science ®Google Scholar
• ChenILChenYLTzengCCChenISSynthesis and cytotoxic evaluation of some 4-anilinofuro[2,3-b]quinoline derivativesHelv Chim Acta200285722142221
   Web of Science ®Google Scholar
• FinlayGJRiouJFBaguleyBCFrom amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivativesEur J Cancer199632A47087148695277
   PubMed Web of Science ®Google Scholar
• ZhaoYLChenYLTzengCCChenILWangTCHanCHSynthesis and cytotoxic evaluation of certain 4-(phenylamino)furo[2,3-b]quinoline and 2-(furan-2-yl)-4-(phenylamino)quinoline derivativesChem Biodivers20052220521417191973
   PubMed Web of Science ®Google Scholar
• ChenYLChenILWangTCHanCHTzengCCSynthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivativesEur J Med Chem200540992893415913847
   PubMed Web of Science ®Google Scholar
• PeggDGWatkinsJRGrazianoMJMcKennaMJSubchronic intravenous toxicity of the antineoplastic drug, amsacrine, in male Wistar ratsFundam Appl Toxicol199632145528812219
   PubMedGoogle Scholar
• KestellPPaxtonJWEvansPCDisposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5- dimethyl-4-acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in miceCancer Res19905035035082297692
   PubMed Web of Science ®Google Scholar
• Solid lipid nanoparticles: an effective lipid based technology for poorly water soluble drugsInt J Pharm Sci Rev Res2010527890
   Google Scholar
• HouDXieCHuangKZhuCThe production and characteristics of solid lipid nanoparticles (SLNs)Biomaterials200324101781178512593960
   PubMed Web of Science ®Google Scholar
• MallipeddiRRohanLCProgress in antiretroviral drug delivery using nanotechnologyInt J Nanomedicine2010553354720957115
   PubMed Web of Science ®Google Scholar
• PeruginiPTomasiCVettorMInfluence of SLN matrix modification on “in vitro” and “in vivo” nanoparticle performancesInt J Pharmacy Pharm Sci2010233742
   Google Scholar
• KosteraVSKuksPFLangeRTalsmaHParticle size in parenteral fat emulsions, what are the true limitations?Int J Pharm19961341–2235238
   Web of Science ®Google Scholar
• MarianecciCDi MarzioLRinaldiFCarafaMAlhaiqueFPulmonary delivery: innovative approaches and perspectivesJ Biomater Nanobiotechnol201125567575
   Google Scholar
• NanjwadeBKPatelDJUdhaniRAManviFVFunctions of lipids for enhancement of oral bioavailability of poorly water-soluble drugsSci Pharm201179470572722145101
   PubMedGoogle Scholar
• YuanHWangLLDuYZYouJHuFQZengSPreparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsificationColloids Surf B Biointerfaces200760217417917656075
   PubMed Web of Science ®Google Scholar
• FangCShiBPeiYYEffect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticlesActa Pharmacol Sin200526224224915663906
   PubMed Web of Science ®Google Scholar
• MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
   PubMed Web of Science ®Google Scholar
• FreitasCMüllerRHEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInt J Pharm19981682221229
   Web of Science ®Google Scholar
• HuYXieJTongYWWangCHEffect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cellsJ Control Release2007118171717241684
   PubMed Web of Science ®Google Scholar
• WanFYouJSunYStudies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitroInt J Pharm20083591210411018450394
   PubMed Web of Science ®Google Scholar
• StormGBelliotSODaemenTLasicDDSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev19951713148
   Web of Science ®Google Scholar
• RombergBHenninkWEStormGSheddable coatings for long-circulating nanoparticlesPharm Res2008251557117551809
   PubMed Web of Science ®Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• FreitasCMüllerRHCorrelation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phaseEur J Pharm Biopharm199947212513210234536
   PubMed Web of Science ®Google Scholar
• VenkateswarluVManjunathKPreparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release200495362763815023472
   PubMed Web of Science ®Google Scholar
• FangYPLinYKSuYHFangJYTryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner coreChem Pharm Bull (Tokyo)201159226627121297310
   PubMed Web of Science ®Google Scholar
• ChenDBYangTZLuWLZhangQIn vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxelChem Pharm Bull (Tokyo)200149111444144711724235
   PubMed Web of Science ®Google Scholar
• UnerMYenerGImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectivesInt J Nanomedicine20072328930018019829
   PubMed Web of Science ®Google Scholar
• ElbayoumiTATorchilinVPEnhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell linesEur J Pharm Sci200732315916817707615
   PubMed Web of Science ®Google Scholar
• ShenJWangYPingQXiaoYHuangXMucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug deliveryJ Control Release2009137321722319393270
   PubMed Web of Science ®Google Scholar
• ColeAJDavidAEWangJGalbánCJYangVCMagnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticlesBiomaterials201132266291630121684593
   PubMed Web of Science ®Google Scholar
• YoshizawaYKonoYOgawaraKKimuraTHigakiKPEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacyInt J Pharm20114121–213214121507344
   PubMed Web of Science ®Google Scholar
• JiaLShenJZhangDIn vitro and in vivo evaluation of oridonin- loaded long circulating nanostructured lipid carriersInt J Biol Macromol201250352352922301003
   PubMed Web of Science ®Google Scholar
• TsaiMJHuangYBWuPCOral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluationsJ Pharm Sci2011100254755720740670
   PubMed Web of Science ®Google Scholar
• FangYPWuPCTzengCCChenYLLinHLTsaiYHA new antitumor agent, (3-chloro-7-methoxyfuro[2,3-b]-quinolin-4-yl)- (4-methoxyphenyl), loaded in solid lipid nanoparticles: characterization and pharmacokineticsCurr Nanosci201282266273
   Web of Science ®Google Scholar
• MoghimiSMHunterACMurrayJCLong-circulating and target-specific nanoparticles: theory to practicePharmacol Rev200153228331811356986
   PubMed Web of Science ®Google Scholar
• ManjunathKVenkateswarluVPharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administrationJ Control Release2005107221522816014318
   PubMed Web of Science ®Google Scholar
• LiuMLiHLuoGLiuQWangYPharmacokinetics and biodistribution of surface modification polymeric nanoparticlesArch Pharm Res200831454755418449515
   PubMed Web of Science ®Google Scholar
• AndréPKomurian-PradelFDeforgesSCharacterization of low- and very-low-density hepatitis C virus RNA-containing particlesJ Virol200276146919692812072493
   PubMed Web of Science ®Google Scholar